Literature DB >> 28831555

Reply to "Association of HLA-B27 and its subtypes with ankylosing spondylitis and clinical manifestations of ankylosing spondylitis in different HLA-B27 subtypes: comment on the article by Lin et al."

Hai Lin1, Yi-Zhen Gong2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28831555     DOI： 10.1007/s00296-017-3789-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  3 in total

1.  Effect of HLA-B*27 and its subtypes on clinical manifestations and severity of ankylosing spondylitis in Iranian patients.

Authors:  Sasan Fallahi; Mahdi Mahmoudi; Mohammad Hossein Nicknam; Farhad Gharibdoost; Elham Farhadi; Azad Saei; Keramat Nourijelyani; Nooshin Ahmadzadeh; Ahmad Reza Jamshidi
Journal:  Iran J Allergy Asthma Immunol       Date:  2013-08-28       Impact factor: 1.464

2.  Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia.

Authors:  Mohammed A Omair; Fatmah K AlDuraibi; Mohammed K Bedaiwi; Sultana Abdulaziz; Waleed Husain; Maha El Dessougi; Hind Alhumaidan; Hana J Al Khabbaz; Ibrahim Alahmadi; Maha A Omair; Salman Al Saleh; Khalid Alismael; Moheeb Al Awwami
Journal:  Clin Rheumatol       Date:  2017-04-29       Impact factor: 2.980

3.  Clinical Features in Juvenile-Onset Ankylosing Spondylitis Patients Carrying Different B27 Subtypes.

Authors:  Yikun Mou; Pingping Zhang; Qiuxia Li; Zhiming Lin; Zetao Liao; Qiujing Wei; Jieruo Gu
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411
  3 in total
  1 in total

Review 1.  Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis.

Authors:  Alexandra-Diana Diaconu; Alexandr Ceasovschih; Victorița Șorodoc; Cristina Pomîrleanu; Cătălina Lionte; Laurențiu Șorodoc; Codrina Ancuța
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.